-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Corcept Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Corcept Therapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $46.6M, a 49.5% increase year-over-year.
- Corcept Therapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $143M, a 46.1% increase year-over-year.
- Corcept Therapeutics Inc annual Operating Income (Loss) for 2023 was $107M, a 4.75% decline from 2022.
- Corcept Therapeutics Inc annual Operating Income (Loss) for 2022 was $113M, a 9.51% decline from 2021.
- Corcept Therapeutics Inc annual Operating Income (Loss) for 2021 was $124M, a 2.91% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)